Involvement of Wnt signaling in dermal fibroblasts

American Journal of Pathology

Volumn 176, Issue 2, 2010, Pages 721-732

  Kabashima, Kenji ^a,b   Sakabe, Jun Ichi ^a   Yoshiki, Ryutaro ^a   Tabata, Yasuhiko ^c   Kohno, Kimitoshi ^a   Tokura, Yoshiki ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; COLLAGEN; DICKKOPF 1 PROTEIN; GROWTH HORMONE; MESSENGER RNA; RECOMBINANT PROTEIN; SMALL INTERFERING RNA; THYROTROPIN; WNT PROTEIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DISEASE; BONE RADIOGRAPHY; CASE REPORT; CELL FUNCTION; CELL PROLIFERATION; CLUBBING FINGERS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; DERMIS; DNA MICROARRAY; EAR; ELASTIC FIBER; FAMILY HISTORY; FEMALE; FIBROBLAST CULTURE; FOREHEAD; GROWTH HORMONE BLOOD LEVEL; HAND MALFORMATION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; HYPERTROPHIC OSTEOARTHROPATHY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MELANOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PACHYDERMOPERIOSTOSIS; PATHOGENESIS; PERIOSTOSIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEBACEOUS GLAND DISEASE; SIGNAL TRANSDUCTION; SKIN BIOPSY; SKIN FIBROBLAST; STAINING; SWEAT GLAND DISEASE; THYROTROPIN BLOOD LEVEL; UNINDEXED SEQUENCE;

EID: 76149103593     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090454     Document Type: Article

References (43)

1. Vogl A, Goldfischer S: Pachydermoperiostosis: primary or idiopathic hypertrophic osteoarthropathy. Am J Med 1962, 33:166-187
2. Shawarby K, Ibrahim MS: Pachydermoperiostosis. A review of literature and report on four cases. Br Med J 1962, 1:763-766
3. Rimoin DL: Pachydermoperiostosis (idiopathic clubbing and periostosis): genetic and physiologic considerations. N Engl J Med 1965, 272:923-931
4. Jajic I, Jajic Z, Grazio S: Minor but important symptoms and signs in primary hypertrophic osteoarthropathy. Clin Exp Rheumatol 2001, 19:357-358
5. Touraine A, Solente G, Gole A: Un syndrome osteodermopathique: la pachydermie plicaturee avec pachyperiostose des extremites. Presse Med 1935, 43:1820-1824
6. Uppal S, Diggle CP, Carr IM, Fishwick CW, Ahmed M, Ibrahim GH, Helliwell PS, Latos-Bielenska A, Phillips SE, Markham AF, Bennett CP, Bonthron DT: Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy. Nat Genet 2008, 40: 789-793
7. Castori M, Sinibaldi L, Mingarelli R, Lachman RS, Rimoin DL, Dallapiccola B: Pachydermoperiostosis: an update. Clin Genet 2005, 68:477-486
8. Kornak U, Mundlos S: Genetic disorders of the skeleton: a developmental approach. Am J Hum Genet 2003, 73:447-474
9. Botchkarev VA, Sharov AA: BMP signaling in the control of skin development and hair follicle growth. Differentiation 2004, 72:512-526
10. Zorn AM: Wnt signalling: antagonistic Dickkopfs. Curr Biol 2001, 11:R592-595
11. Kawano Y, Kypta R: Secreted antagonists of the Wnt signalling pathway. J Cell Sci 2003, 116:2627-2634
12. Mao B, Wu W, Davidson G, Marhold J, Li M, Mechler BM, Delius H, Hoppe D, Stannek P, Walter C, Glinka A, Niehrs C: Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature 2002, 417:664-667
13. Mao B, Wu W, Li Y, Hoppe D, Stannek P, Glinka A, Niehrs C: LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 2001, 411:321-325
14. Glinka A, Wu W, Delius H, Monaghan AP, Blumenstock C, Niehrs C: Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 1998, 391:357-362
15. Grotewold L, Ruther U: The Wnt antagonist Dickkopf-1 is regulated by Bmp signaling and c-Jun and modulates programmed cell death. EMBO J 2002, 21:966-975
16. Yamaguchi Y, Itami S, Watabe H, Yasumoto K, Abdel-Malek ZA, Kubo T, Rouzaud F, Tanemura A, Yoshikawa K, Hearing VJ: Mesenchymalepithelial interactions in the skin: increased expression of dickkopf1 by palmoplantar fibroblasts inhibits melanocyte growth and differentiation. J Cell Biol 2004, 165:275-285
17. Yamaguchi Y, Passeron T, Watabe H, Yasumoto K, Rouzaud F, Hoashi T, Hearing VJ: The effects of dickkopf 1 on gene expression and Wnt signaling by melanocytes: mechanisms underlying its suppression of melanocyte function and proliferation. J Invest Dermatol 2007, 127:1217-1225
18. Andl T, Reddy ST, Gaddapara T, Millar SE: WNT signals are required for the initiation of hair follicle development. Dev Cell 2002, 2:643-653
19. Masuda K, Moriwaki S, Takigawa M, Furukawa F, Higashishiba T, Fukamizu H: A case of pachydermoperiostosis. Rinsho Hifuka (Japanese) 2000, 54:398-401
20. Kabashima K, Banks TA, Ansel KM, Lu TT, Ware CF, Cyster JG: Intrinsic lymphotoxin-beta receptor requirement for homeostasis of lymphoid tissue dendritic cells. Immunity 2005, 22:439-450
21. Kabashima K, Haynes NM, Xu Y, Nutt SL, Allende ML, Proia RL, Cyster JG: Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism. J Exp Med 2006, 203:2683-2690
22. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2[-Delta Delta C(T)] method. Methods 2001, 25:402-408
23. Kabashima K, Sakabe J, Yamada Y, Tokura Y: "Nagashima-type" keratosis as a novel entity in the palmoplantar keratoderma category. Arch Dermatol 2008, 144:375-379
24. Maekawa M, Yamamoto T, Tanoue T, Yuasa Y, Chisaka O, Nishida E: Requirement of the MAP kinase signaling pathways for mouse preimplantation development. Development 2005, 132:1773-1783
25. Kushibiki T, Matsumoto K, Nakamura T, Tabata Y: Suppression of tumor metastasis by NK4 plasmid DNA released from cationized gelatin. Gene Ther 2004, 11:1205-1214
26. Matucci-Cerinic M, Sacerdoti L, Perrone C, Carossino A, Cagnoni ML, Jajic I, Lotti T: Pachydermoperiostosis (primary hypertrophic osteoarthropathy): in vitro evidence for abnormal fibroblast proliferation. Clin Exp Rheumatol 1992, 10 Suppl 7:57-60
27. Kim SE, Choi KY: EGF receptor is involved in WNT3a-mediated proliferation and motility of NIH3T3 cells via ERK pathway activation. Cell Signal 2007, 19:1554-1564
28. Fine A, Goldstein RH: The effect of PGE2 on the activation of quiescent lung fibroblasts. Prostaglandins 1987, 33:903-913
29. Korn JH, Halushka PV, LeRoy EC: Mononuclear cell modulation of connective tissue function: suppression of fibroblast growth by stimulation of endogenous prostaglandin production. J Clin Invest 1980, 65:543-554
30. Niida A, Hiroko T, Kasai M, Furukawa Y, Nakamura Y, Suzuki Y, Sugano S, Akiyama T: DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway. Oncogene 2004, 23:8520-8526
31. Kahn MF, Chamot AM: SAPHO syndrome. Rheum Dis Clin North Am 1992, 18:225-246
32. Oduber CE, van der Horst CM, Hennekam RC: Klippel-Trenaunay syndrome: diagnostic criteria and hypothesis on etiology. Ann Plast Surg 2008, 60:217-223
33. Ehrig T, Cockerell CJ: Buschke-Ollendorff syndrome: report of a case and interpretation of the clinical phenotype as a type 2 segmental manifestation of an autosomal dominant skin disease. J Am Acad Dermatol 2003, 49:1163-1166
34. Hellemans J, Preobrazhenska O, Willaert A, Debeer P, Verdonk PC, Costa T, Janssens K, Menten B, Van Roy N, Vermeulen SJ, Savarirayan R, Van Hul W, Vanhoenacker F, Huylebroeck D, De Paepe A, Naeyaert JM, Vandesompele J, Speleman F, Verschueren K, Coucke PJ, Mortier GR: Loss-of-function mutations in LEMD3 result in osteopoikilosis. Buschke-Ollendorff syndrome and melorheostosis. Nat Genet 2004, 36:1213-1218
35. Raisz LG, Pilbeam CC, Fall PM: Prostaglandins: mechanisms of action and regulation of production in bone. Osteoporos Int 1993, 3 Suppl 1:136-140
36. Fontenay-Roupie M, Dupuy E, Berrou E, Tobelem G, Bryckaert M: Increased proliferation of bone marrow-derived fibroblasts in primitive hypertrophic osteoarthropathy with severe myelofibrosis. Blood 1995, 85:3229-3238
37. Fedi P, Bafico A, Nieto Soria A, Burgess WH, Miki T, Bottaro DP, Kraus MH, Aaronson SA: Isolation and biochemical characterization of the human Dkk-1 homologue, a novel inhibitor of mammalian Wnt signaling. J Biol Chem 1999, 274:19465-19472
38. Yamaguchi Y, Passeron T, Hoashi T, Watabe H, Rouzaud F, Yasumoto K, Hara T, Tohyama C, Katayama I, Miki T, Hearing VJ: Dickkopf 1 (DKK1) regulates skin pigmentation and thickness by affecting Wnt/beta-catenin signaling in keratinocytes. FASEB J 2008, 22:1009-1020
39. Qiang YW, Endo Y, Rubin JS, Rudikoff S: Wnt signaling in B-cell neoplasia. Oncogene 2003, 22:1536-1545
40. Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B, Shaughnessy JD Jr: The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 2003, 349:2483-2494
41. Morvan F, Boulukos K, Clement-Lacroix P, Roman Roman S, Suc-Royer I, Vayssiere B, Ammann P, Martin P, Pinho S, Prognonec P, Mollat P, Niehrs C, Baron R, Rawadi G: Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Miner Res 2006, 21:934-945
42. Gonzalez-Sancho JM, Aguilera O, Garcia JM, Pendas-Franco N, Pena C, Cal S, Garcia de Herreros A, Bonilla F, Munoz A: The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer. Oncogene 2005, 24:1098-1103
43. Polakis P: Wnt signaling and cancer. Genes Dev 2000, 14:1837-1851 44. Matucci-Cerinic M, Lotti T, Jajic I, Pignone A, Bussani C, Cagnoni M: The clinical spectrum of pachydermoperiostosis (primary hypertrophic osteoarthropathy). Medicine (Baltimore) 1991, 70:208-214